Evidence map›Paper›PMID 28680961›Full record

ArticleOncology and therapy2017

Bone Marrow Necrosis in Newly Diagnosed Acute Leukemia: Two Case Reports and Review of the Literature.

Adrien Quintela, Pierre Sujobert, Isabelle Tigaud, Sandrine Hayette, Martine Ffrench, Gilles Salles, Xavier Thomas, Adriana Plesa

Abstract read
In one paragraph

Article in Oncology and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adrien QuintelaDepartment of Hematology, CHU Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France.
Pierre SujobertLaboratory of Molecular Biology, CHU Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France.
Isabelle TigaudLaboratory of Cytogenetics, CHU Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France.
Sandrine HayetteLaboratory of Molecular Biology, CHU Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France.
Martine FfrenchDepartment of Hematology, CHU Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France.
Gilles SallesDepartment of Hematology, CHU Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France.
Xavier ThomasDepartment of Hematology, CHU Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France.
Adriana PlesaLaboratory of Hematology and Flow Cytometry, CHU Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone marrow necrosis (BMN) in acute leukemia is a rare histopathological entity at the time of initial diagnosis. However, it represents an important diagnostic and prognostic challenge. Two cases of BMN are reported: a 44-year-old patient with B cell precursor (BCP) acute lymphoblastic leukemia (ALL) and a 27-year-old man with FAB-M5 acute myeloid leukemia (AML) who both presented with bone marrow failure and extensive necrosis. From these clinical cases, we conducted a brief review of the literature.

Indexed as

Acute leukemiaBone marrow necrosisChemotherapyPrognosis

Identifiers

PMID28680961
PMCPMC5488115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.